Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation

来源 :World Journal of Gastroenterology | 被引量 : 0次 | 上传用户:Jackyx
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM: To explore the role of CDX2 in the multi-drug resistance (MDR) process of gastric cancer in vitro and in vivo . METHODS: A cisplatin-resistant gastric cancer cell line with stable downregulation of CDX2 was established. mRNA and protein expression levels of CDX2, survivin, cyclin D1, and c-Myc were detected by western blotting and semi-quantitative reverse-transcriptase polymerase chain reaction (RT-PCR). The influence of downregulation of CDX2 on MDR was assessed by measuring IC50 of SGC7901/DDP cells to cisplatin, doxorubicin, and 5-fluorouracil, rate of doxorubicin efflux, apoptosis, and cell cycle progression detected by flow cytometry. In addition, we determined the in vivo effects of CDX2 small interfering RNA (siRNA) on tumor size, and apoptotic cells in tumor tissues were detected by deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling and hematoxylin and eosin staining. RESULTS: CDX2 siRNA led to downregulation of endogenous CDX2 mRNA (0.31 ± 0.05 vs 1.10 ± 0.51, 0.31 ± 0.05 vs 1.05 ± 0.21, P = 0.003) and protein (0.12 ± 0.08 vs 0.51 ± 0.07, 0.12 ± 0.08 vs 0.55 ± 0.16, P = 2.57 × 10 -4) expression. It significantly promoted the sensitivity of SGC7901/DDP cells to cisplatin (0.12 ± 0.05 vs 0.33 ± 0.08, 0.12 ± 0.05 vs 0.39 ± 0.15, P = 0.001), doxorubicin (0.52 ± 0.13 vs 4.11 ± 1.25, 0.52 ± 0.13 vs 4.05 ± 1.44, P = 2.81 × 10-4), and 5-fluorouracil (0.82 ± 0.13 vs 2.81 ± 0.51, 0.82 ± 0.13 vs 3.28 ± 1.03, P = 1.71 × 10-4). Flow cytometry confirmed that the percentage of apoptotic cells increased after CDX2 downregulation (32.15% ± 2.15% vs 17.63% ± 3.16%, 32.15% ± 2.15% vs 19.3% ± 2.25%, P = 1.73 × 10-6). This notion was further supported by the observation that downregulation of CDX2 blocked entry into the S-phase of the cell cycle (31.53% ± 3.78% vs 65.05% ± 7.25%, 31.53% ± 3.78% vs 62.27% ± 5.02%, P = 7.55 × 10-7). Furthermore, downregulation of CDX2 significantly increased intracellular accumulation of doxorubicin (0.21 ± 0.06 vs 0.41 ± 0.11, 0.21 ± 0.06 vs 0.40 ± 0.08, P = 0.003). In molecular studies, semiquantitative RT-PCR and western blotting revealed that CDX2 downregulation could inhibit expression of c-Myc, survivin and cyclin D1. CONCLUSION: CDX2 may be involved in regulating multiple signaling pathways in reversing MDR, suggesting that CDX2 may represent a novel target for gastric cancer therapy. AIM: To explore the role of CDX2 in the multi-drug resistance (MDR) process of gastric cancer in vitro and in vivo. METHODS: A cisplatin-resistant gastric cancer cell line with stable downregulation of CDX2 was established. MRNA and protein expression levels of CDX2, survivin, cyclin D1, and c-Myc were detected by western blotting and semi-quantitative reverse-transcriptase polymerase chain reaction (RT-PCR). The influence of downregulation of CDX2 on MDR was assessed by IC50 of SGC7901 / DDP cells to cisplatin, doxorubicin, and 5-fluorouracil, rate of doxorubicin efflux, apoptosis, and cell cycle progression detected by flow cytometry. In addition, we determined the in vivo effects of CDX2 small interfering RNA (siRNA) on tumor size, and apoptotic cells in tumor tissues were detected by deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling and hematoxylin and eosin staining. RESULTS: CDX2 siRNA led to downregulation of endogenous CDX2 mRNA (0.31 ± 0.05 vs. 1.10 ± 0.51, 0.31 ± 0.05 vs 1.05 ± 0.21, P = 0.003) and protein (0.12 ± 0.08 vs 0.51 ± 0.07, 0.12 ± 0.08 vs 0.55 ± 0.16, P = 2.57 × 10 -4) expression. It was promoted the sensitivity of SGC7901 / DDP cells to cisplatin (0.12 ± 0.05 vs 0.33 ± 0.08, 0.12 ± 0.05 vs 0.39 ± 0.15, P = 0.001), doxorubicin (0.52 ± 0.13 vs 4.11 ± 1.25, 0.52 ± 0.13 vs 4.05 ± 1.44, P = 2.81 × 10-4), and 5-fluorouracil (0.82 ± 0.13 vs. 2.81 ± 0.51, 0.82 ± 0.13 vs 3.28 ± 1.03, P = 1.71 × 10-4). Flow cytometry confirmed that the percentage of apoptotic cells increased after CDX2 downregulation (32.15 % ± 2.15% vs 17.63% ± 3.16%, 32.15% ± 2.15% vs 19.3% ± 2.25%, P = 1.73 × 10-6). This notion was further supported by the observation that downregulation of CDX2 blocked entry into the S- phase of the cell cycle (31.53% ± 3.78% vs 65.05% ± 7.25%, 31.53% ± 3.78% vs 62.27% ± 5.02%, P = 7.55 × 10-7.) Furthermore, downregulation of CDX2 significantly increased intracellular accumulation of dox orubicin (0.21 ± 0.06 vs 0.41 ± 0.11, 0.21 ± 0.06 vs 0.40 ± 0.08, P = 0.003). In molecular studies, semiquantitative RT-PCR and western blotting revealed that CDX2 downregulation could inhibit expression of c-Myc, survivin and cyclin D1. CONCLUSION: CDX2 may be involved in regulating multiple signaling pathways in reversing MDR, suggesting that CDX2 may represent a novel target for gastric cancer therapy.
其他文献
细胞凋亡(Apoptosis)的概念是由Kerr等于1972年提出来的,由于检测技术的限制,长期以来未能引起重视.80年代末,随着分子生物学、细胞生物学等理论和技术的发展,凋亡检测技术也有了一
从边防哨所到雪域阵地,从秦川大地到热带丛林,刘应华徒步走遍了高寒、边远的座座军营,用镜头定格下了一幅幅难忘画面;从雨雪冰冻灾害到汶川特大地震,从西南抗旱到玉树救灾,刘
  通过试验跟踪和表面形貌状态检测,研究优质低碳碳素结构钢丝表面花纹和暗斑产生的原因及形成机制。结果表明:当热轧线材表面氧化膜颜色均匀一致呈灰黑色时,成品钢丝表面不会
会议
  金属制品零部件热处理(淬火或渗碳淬火)和机械加工中产生的氢,不仅对金属材料的力学性能产生影响,而且会导致延迟断裂。对紧固件电镀锌氢脆进行分析,并提出预防措施:电镀锌前
  录井钢丝广泛应用在石油、天然气、地质探测等领域,其工作环境常含有大量的硫化氢、二氧化碳、氯化物等强腐蚀介质。针对影响录井钢丝使用寿命的主要因素:环境、表面损伤、
会议
  介绍我国钢丝绳标准的5个发展阶段。(1)参照苏联标准模式,将钢丝绳品种结构与技术条件标准分开,制订了国家标准及冶金部标准。(2)20世纪70年代重新起草钢丝绳标准,按用途或
会议
  剑麻钢丝绳芯是钢丝绳行业应用日渐增多的一种天然纤维芯,文章结合剑麻特性及国内剑麻钢丝绳芯的设计,制造和使用实践,对GB/T15030-2009《剑麻钢丝绳芯》标准及其与旧版本相
锑冶炼工人在工作环境中接触的毒物除锑及其化合物外,还有铅、砷、二氧化硫及挥发性多环芳香烃等。按照工作性质将研究对象分为4个职业组:锑接触组为至少在锑冶炼车间工作3
  以Φ12.5mm SWRH82B盘条为例研究酸洗液浓度对盘条力学性能的影响。对盘条化学成分,力学性能和组织进行分析,盘条酸洗后性能波动的主要原因是随着硫酸浓度的升高,钢中氢
  研制水溶性防锈润滑剂,进行了试验测试和生产验证,将研制的FT-1水溶性防锈润滑剂与日本进口的MAX-3干膜防锈润滑剂进行对比,通过膜厚、吸湿性、防锈性和润滑性的测试,PT-1
会议